The price set by the Swiss drugmaker Novartis may be the world’s highest for a single treatment — prompting renewed debate about how society will pay for gene-therapy breakthroughs.
The New York Times
By KATIE THOMAS from NYT Health https://nyti.ms/2HYjDo2
May 23, 2019 at 02:00PM
No comments:
Post a Comment